RESUMEN
Staphylococcal superantigens (sAgs), such as toxic shock syndrome toxin 1 (TSST-1), induce massive cytokine production, which may result in toxic shock syndrome (TSS) and sepsis. Recently, we reported that in vitro studies in human peripheral blood mononuclear cells (PBMC) do not reflect the immunological situation of the host, because after exposure to superantigens (sAgs) in vivo, mononuclear cells (MNC) leave the circulation and migrate to organs, e.g., the spleen, liver and lung. Our experimental model of choice is the rabbit because it is comparable to humans in its sensitivity to sAg. T cell activation has been assessed by lymphocyte proliferation and IL-2 gene expression after in vivo challenge with TSST-1 and the mutant antigens; expression of the genes of proinflammatory cytokines were taken as indicators for the inflammatory reaction after the combined treatment with TSST-1 and LPS. The question as to whether the biological activities of TSST-1, e.g., lymphocyte extravasation, toxicity and increased sensitivity to LPS, are mediated by T cell activation or activation by MHC II-only, are unresolved and results are contradictory. We have addressed this question by studying these reactions in vivo, with two TSST-1 mutants: one mutated at the MHC binding site (G31R) with reduced MHC binding with residual activity still present, and the other at the T cell binding site (H135A) with no residual function detectable. Here, we report that the mutant G31R induced all the biological effects of the wild type sAg, while the mutant with non-functional TCR binding did not retain any of the toxic effects, proving the pivotal role of T cells in this system.
Asunto(s)
Toxinas Bacterianas/farmacología , Citocinas/metabolismo , Enterotoxinas/farmacología , Activación de Linfocitos/efectos de los fármacos , Proteínas Mutantes/farmacología , Mutación , Superantígenos/farmacología , Linfocitos T/efectos de los fármacos , Animales , Toxinas Bacterianas/genética , Toxinas Bacterianas/inmunología , Sitios de Unión , Linfocitos T CD4-Positivos/efectos de los fármacos , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/metabolismo , Linfocitos T CD8-positivos/efectos de los fármacos , Linfocitos T CD8-positivos/inmunología , Linfocitos T CD8-positivos/metabolismo , Proliferación Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Enterotoxinas/genética , Enterotoxinas/inmunología , Femenino , Expresión Génica/efectos de los fármacos , Interacciones Huésped-Patógeno , Activación de Linfocitos/inmunología , Proteínas Mutantes/genética , Proteínas Mutantes/inmunología , Unión Proteica , Conejos , Superantígenos/genética , Superantígenos/inmunología , Linfocitos T/inmunología , Linfocitos T/metabolismoRESUMEN
Staphylococcal toxic shock syndrome toxin 1 (TSST-1) is the major cause of toxic shock syndrome and is important in the pathophysiology of staphylococcal septic shock. Our study about the biological effects of TSST-1 in the rabbit 3 and 6 h and 7 days postinjection provides evidence that TSST-1 induces leukopenia, lymphopenia, and monocytopenia as a result of extravasation of cells in a Vss-unrestricted manner. Cells in the circulation, reduced significantly in numbers, show the same phenotypic distribution as before TSST-1 injection. Three hours post-in vivo TSST-1 injection, we demonstrated compartmentalization of the response. By quantitative RT-PCR, the induction of mRNA expression of TH1 and inflammatory cytokines in the spleen and lung and a complete lack of induction in PBMC could be shown. Proliferation assays revealed that 3 h after TSST-1, PBMC were neither activated nor responsive to in vitro restimulation, even when IL-2 was added. In contrast, 7 days later, PBMC and spleen cells were anergic: showing no response to TSST-1 but a vigorous response upon addition of IL-2. The results presented extend our understanding of the pathophysiology of toxic and septic shock as a result of superantigen toxin-producing Staphylococcus aureus. Demonstration of compartmentalization of the response proves that erroneous conclusions could be drawn by the exclusive analysis of PBMCs. The results reveal further that in nonresponsiveness to the antigen, different immunological mechanisms may be operational. Measurements of the induction of cytokine gene activation provide important complementary information to that of serum cytokine levels.
Asunto(s)
Toxinas Bacterianas/farmacología , Anergia Clonal , Enterotoxinas/farmacología , Receptores de Antígenos de Linfocitos T alfa-beta/inmunología , Staphylococcus aureus/inmunología , Superantígenos/farmacología , Animales , Células Cultivadas , Quimiotaxis , Citocinas/biosíntesis , Citocinas/genética , Enterotoxinas/fisiología , Femenino , Leucocitos/inmunología , Leucocitos/patología , Leucopenia/sangre , Leucopenia/inmunología , Pulmón/inmunología , Activación de Linfocitos , Linfopenia/sangre , Linfopenia/inmunología , ARN Mensajero/biosíntesis , Conejos , Proteínas Recombinantes/farmacología , Bazo/inmunología , Superantígenos/fisiología , Factores de TiempoRESUMEN
Myeloid lineage-derived dendritic cells (DCs) are considered the professional antigen-presenting cell type responsible for eliciting T-cell-mediated immune responses. Acute myelogenous leukemia (AML) is a disease in which tumor antigens are expressed by the malignant clone that also has the potential to differentiate into DC-like cells (leukemic DCs) with antigen-presenting capacity. This study investigated whether the constitutive expression of the cytokine interleukin-7 (IL-7) in primary AML cells during their differentiation toward leukemic DCs results in superior antigen-presenting cells. A bicistronic retroviral vector encoding the IL-7 cytokine and the surface immunoselectable low-affinity nerve growth factor receptor (LNGFr) gene was constructed and used for transduction experiments. A serum-free system was used to transduce and differentiate leukemic cells toward leukemic DCs. The study included 8 patients with AML. The transduction efficiency with the cytokine vector varied among patients, ranging from 5% to 30% as judged by LNGFr expression. The leukemic origin of the transduced cells was confirmed in a patient with a chromosomal translocation t(9:11) by fluorescence in situ hybridization analysis. Cytokine modified-cells consistently secreted IL-7 (mean, 415 pg +/- 190/10(6) cells/48 hours; n = 5). We demonstrate that IL-7-transduced cells are included in the differentiated leukemic DC subset, and, as shown in a particular case, that about half of the mature CD80(+) and CD83(+) populations coexpress the LNGFr transgene. In addition, IL-7-modified leukemic cells induce stronger allo-T-cell stimulation and higher amounts of IL-2 production in T cells compared with control groups. Finally, cytokine-transduced leukemic DCs can effectively prime and generate cytotoxic T lymphocytes against autologous leukemic blasts.
Asunto(s)
Células Dendríticas/metabolismo , Expresión Génica , Interleucina-7/genética , Leucemia Mieloide Aguda/patología , Retroviridae/genética , Células Presentadoras de Antígenos/inmunología , Antígenos CD , Antígeno B7-1/análisis , Diferenciación Celular , Células Dendríticas/patología , Genes , Vectores Genéticos , Humanos , Inmunoglobulinas/análisis , Hibridación Fluorescente in Situ , Interleucina-2/análisis , Interleucina-7/inmunología , Interleucina-7/metabolismo , Leucemia Mieloide Aguda/inmunología , Leucemia Mieloide Aguda/metabolismo , Prueba de Cultivo Mixto de Linfocitos , Glicoproteínas de Membrana/análisis , Factor de Crecimiento Nervioso/genética , Proteínas Recombinantes de Fusión , Linfocitos T/química , Linfocitos T/inmunología , Linfocitos T Citotóxicos/inmunología , Antígeno CD83RESUMEN
Toxic shock syndrome toxin-1 (TSST-1), a superantigen produced by Staphylococcus aureus, is a potent stimulator of the immune system. T-cells are activated by crosslinking of MHC class II molecules on antigen presenting cells with T-cell receptors (TCR). TSST-1 is associated with the majority of the cases of menstrual staphylococcal toxic shock, a severe and life-threatening multisystem disorder. Even though antibody mediated protection has been studied, information on antibody specificity directed to individual antigenic determinants of the protein is incomplete. To obtain immunogens with low toxicity, we generated a double-site mutant (dmTSST-1), modified at solvent-exposed residues predicted to be important for both MHC class II and TCR binding, and detoxified recombinantly expressed TSST-1 (rTSST-1) as well as native TSST-1 (nTSST-1) isolated from Staphylococcus aureus by treatment with formaldehyde. Rabbits were immunized with rTSST-1, nTSST-1, dmTSST-1, and formaldehyde inactivated toxoids. The sera obtained were used to map the antigen-reactive regions of the molecule and to identify specificities of antibodies induced by immunization with the different antigens. To detect linear antigenic epitopes of TSST-1 the reactivity of the sera with 11-meric peptides having an overhang of four residues, covering the entire molecule of TSST-1, have been studied. We found that sera of TSST-1 immunized rabbits predominantly reacted with N-terminal residues 1-15, while sera generated with formaldehyde inactivated toxoid recognized a total of 7 regions located at the N- and C-terminus and internal sites of TSST-1. Despite different specificities all sera were able to inhibit TSST-1 induced proliferation of human mononuclear cells.